# Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)

> **NCT00132743** · PHASE3 · UNKNOWN · sponsor: **Joselyn Cerezo, MD** · enrollment: 119 (actual)

## Conditions studied

- Cardiovascular Diseases
- Peripheral Vascular Diseases
- Atherosclerosis

## Interventions

- **DEVICE:** Stent
- **BEHAVIORAL:** Supervised Exercise Therapy
- **DRUG:** Cilostazol

## Key facts

- **NCT ID:** NCT00132743
- **Lead sponsor:** Joselyn Cerezo, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2013-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132743, "Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00132743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*